newsfilter
← Latest News
GlobeNewswire·

BioVie Announces Update to Parkinson’s Phase 3 Development Program

CARSON CITY, Nev., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and